Acta Clinica Croatica is a distinguished open-access journal published by SESTRE MILOSRDNICE UNIVERSITY HOSPITAL in Croatia, dedicated to advancing the field of general medicine. With its publication history extending from 1993 to 2023, the journal serves as a vital platform for researchers and healthcare professionals to disseminate and access the latest findings in clinical practice, public health, and medical education. As of 2023, it holds a Q3 ranking in the miscellaneous medicine category, reflecting its significance within the academic community, ranked at #327 out of 636 in Scopus, placing it within the 48th percentile. This journal not only provides a well-respected avenue for original research but also emphasizes the importance of collaboration in healthcare advancements. Open access since 2001, Acta Clinica Croatica ensures that knowledge is widely available, making it an invaluable resource for students, researchers, and practitioners seeking to stay informed and contribute to the evolving landscape of medicine.

The Scandinavian Journal of Pain, published by WALTER DE GRUYTER GMBH, is a pivotal peer-reviewed journal dedicated to advancing the understanding of pain mechanisms, assessment, and management. With its ISSN 1877-8860 and E-ISSN 1877-8879, this journal has been serving the academic community since 2010 and is set to embrace Open Access publishing starting in 2024, ensuring wider dissemination of crucial research findings. Based in Germany, it holds an esteemed reputation in the realms of Anesthesiology and Pain Medicine, achieving a commendable Q2 ranking and 62nd percentile among its peers. In the Neurology (clinical) category, it also ranks Q3 and is placed in the 45th percentile, underscoring its multifaceted contributions to these critical fields. As researchers, professionals, and students delve into its comprehensive articles, they will find valuable insights and emerging trends that drive innovative approaches to pain management and therapy.

The JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.

PAIN MEDICINE, published by Oxford University Press, is a leading journal in the disciplines of Anesthesiology and Pain Medicine. With its ISSN 1526-2375 and E-ISSN 1526-4637, this esteemed journal provides a platform for innovative research and clinical advancements in the field of pain management. With an impressive impact factor attributed to its Q1 ranking in both Anesthesiology and Pain Medicine as well as Q2 in Clinical Neurology for 2023, PAIN MEDICINE ensures high visibility and relevance within the scientific community, noted for its diverse contributions from across the globe. The journal's editorial mission focuses on disseminating significant findings that influence contemporary practices and policies in pain management. Scholars and practitioners are encouraged to engage with this vital resource, which shapes the future of pain medicine from its base at Great Clarendon St, Oxford, England, covering a remarkable timeline from 2000 to 2024.

Revista Española de Anestesiología y Reanimación, an esteemed journal published by Elsevier, serves as a pivotal resource at the intersection of anesthesiology, critical care, and pain medicine. Established in 1963, this journal has continually contributed to the evolving dialogue in these fields, showcasing innovative research that informs practice and enhances patient care. With a current Q3 ranking in both anesthesiology and critical care disciplines as of 2023, it represents a vital platform for clinicians and researchers alike, who are committed to advancing knowledge and improving clinical outcomes. Though not an open-access publication, Revista Española de Anestesiología y Reanimación ensures rigorous peer-review processes and offers insights from leading experts around the globe, making it an invaluable reference for professionals seeking to stay abreast of the latest advancements and trends. Its bibliometric indicators and Scopus rankings affirm its relevance and influence within the academic community, solidifying its role as a cornerstone of anesthesiology and intensive care research.

The Journal of Neuroimmune Pharmacology, published by Springer, is a premier academic journal dedicated to advancing the field of pharmacology intersecting with neuroscience and immunology. With an outstanding impact factor and proudly positioned in the Q1 quartile across multiple categories, this journal showcases cutting-edge research that enhances our understanding of the neuroimmune system and its pharmacological implications. Established in 2006 and continuing through 2024, it serves as a vital resource for researchers, professionals, and students alike, offering insights into the mechanisms of drug action, disease processes, and therapeutic strategies. As a testament to its excellence, the journal ranks prominently in Scopus metrics within its discipline, making it an essential platform for disseminating high-quality research that drives innovation in immunology, allergy, neuroscience, and pharmacology.

The British Journal of Pain is a leading publication in the field of Anesthesiology and Pain Medicine, expertly published by SAGE Publications Ltd from the United Kingdom. With an ISSN of 2049-4637 and an E-ISSN of 2049-4645, this journal has established itself as an essential resource for researchers and practitioners alike, achieving an impressive Q2 ranking in its category for 2023, as well as a Scopus rank of #53 out of 136 in Medicine – Anesthesiology and Pain Medicine. The journal spans a broad scope of topics related to pain management, therapeutic practices, and advancements in treatment methodologies, catering to both ongoing research and clinical applications. Researchers and professionals can access a wealth of knowledge that not only supports the academic community but also drives innovative practices in pain management. The British Journal of Pain recognizes the significance of evidence-based research and its application in clinical settings, making it a vital platform for advancing the understanding of pain and improving patient care.

Journal of Pain Research, published by DOVE MEDICAL PRESS LTD, stands at the forefront of the field of pain management and anesthesia, offering a critical platform for researchers and clinicians dedicated to advancing the understanding of pain and its treatment. With an Open Access model since 2008, this journal enhances accessibility to high-quality research, enabling a global audience to engage with innovative studies and findings. Recognized for its significant contributions, it has achieved a Q2 rank in Anesthesiology and Pain Medicine as of 2023, placing it among the top 30% in its category, and it holds a commendable Scopus rank of 41/136 in its field. Covering a broad scope encompassing clinical trials, pharmacology, and psychosocial aspects of pain, the journal invites submissions that advance both theoretical knowledge and practical applications, making it an invaluable resource for professionals, researchers, and students aiming to improve outcomes in pain management.

Pain Reports, published by LIPPINCOTT WILLIAMS & WILKINS, is a premier open access journal dedicated to advancing the field of anesthesiology and pain medicine. With an impressive impact factor and a ranking of #15 out of 136 in its category, this journal is recognized within the 89th percentile of its field as of 2023. Since its launch in 2016, Pain Reports has provided a vital platform for researchers, clinicians, and professionals to disseminate and access high-quality research articles, reviews, and case studies focused on the multifaceted aspects of pain management and treatment. Through its commitment to open access, the journal ensures that cutting-edge findings are readily available to a global audience, facilitating collaboration and knowledge sharing. With its scope continually evolving until 2024, Pain Reports strives to address the critical and emerging challenges in pain research, making it an essential resource for individuals dedicated to improving patient outcomes and advancing scholarly discourse in pain management.

Pain Physician is a premier journal that plays a critical role in the field of anesthesiology and pain medicine, published by the American Society of Interventional Pain Physicians. With an impressive impact factor and ranked in the Q1 category of Scopus for its significant contributions to the literature, the journal has established itself as a leading source of innovative research and clinical insights since its inception in 1999. Covering a wide array of topics related to pain management, the journal aims to disseminate high-quality studies that inform best practices and enhance patient care. As a well-respected publication, Pain Physician offers essential access to the latest developments and methodologies in pain therapy to researchers, clinicians, and students alike, fostering a deeper understanding of this critical area of medicine. With its commitment to advancing research and practice, Pain Physician is an invaluable resource for those dedicated to improving the quality of life for individuals suffering from chronic pain.